The White House is pushing to overhaul $200 billion in research funding, and a project called Bio Protocol is building an onchain science model that could change how that money flows. The move points to a growing interest in decentralized science, or DeSci, as a way to cut bureaucracy and speed up innovation.
What Bio Protocol is building
Bio Protocol is developing a system that puts research funding and data on a blockchain. The idea is to create a transparent, community-driven model where anyone can contribute to or benefit from scientific discoveries. Instead of relying on traditional grant-making institutions, the protocol aims to let researchers raise money directly from a global pool of supporters. The White House hasn't endorsed Bio Protocol specifically, but the administration's push to reform the $200 billion federal research apparatus aligns with the kind of changes DeSci projects are trying to bring.
The $200 billion reform push
The White House is targeting the way the U.S. government spends roughly $200 billion a year on research. That money currently flows through agencies like the National Institutes of Health and the National Science Foundation, which have their own review processes and bureaucratic layers. The administration wants to streamline that system, making it easier for high-risk, high-reward projects to get funded. The goal is to cut red tape and speed up the translation of lab discoveries into real-world treatments and technologies.
How decentralized science fits in
Decentralized science models like Bio Protocol could complement or even compete with traditional funding channels. By using smart contracts and token-based incentives, these platforms let researchers bypass some of the gatekeeping that slows down conventional grants. Supporters argue that this democratizes access to funding, especially for early-stage or unconventional ideas that might not pass peer review at a major agency. Critics worry about quality control and the risk of hype-driven investment, but the White House's reform push suggests a willingness to experiment with new approaches.
The $200 billion figure is a target, not a guarantee. The administration has not laid out a specific plan for how much of that money would shift to decentralized models. But the direction is clear: the old way of funding research is under scrutiny, and alternatives are being taken seriously.
What happens next
Bio Protocol is still in development, and no launch date has been announced. The White House reform effort is in its early stages, with details expected in coming months. Researchers and investors are watching closely. If the two tracks converge, the result could be a research ecosystem that moves faster, costs less, and includes more voices. But the details will matter — and they're not written yet.
